Affiliation:
1. Universidade Federal do Maranhão, Brazil
2. Universidade Federal de São Paulo, Brazil
3. Universidade Ceuma, Brazil
Abstract
Abstract Introduction: Chronic kidney disease (CKD) and metabolic syndrome (MS) are recognized as public health problems which are related to overweight and cardiometabolic factors. The aim of this study was to develop a model to predict MS in people with CKD. Methods: This was a prospective cross-sectional study of patients from a reference center in São Luís, MA, Brazil. The sample included adult volunteers classified according to the presence of mild or severe CKD. For MS tracking, the k-nearest neighbors (KNN) classifier algorithm was used with the following inputs: gender, smoking, neck circumference, and waist-to-hip ratio. Results were considered significant at p < 0.05. Results: A total of 196 adult patients were evaluated with a mean age of 44.73 years, 71.9% female, 69.4% overweight, and 12.24% with CKD. Of the latter, 45.8% had MS, the majority had up to 3 altered metabolic components, and the group with CKD showed statistical significance in: waist circumference, systolic blood pressure, diastolic blood pressure, and fasting blood glucose. The KNN algorithm proved to be a good predictor for MS screening with 79% accuracy and sensitivity and 80% specificity (area under the ROC curve – AUC = 0.79). Conclusion: The KNN algorithm can be used as a low-cost screening method to evaluate the presence of MS in people with CKD.
Reference44 articles.
1. Multi-morbidity of non communicable diseases and equity in WHO Eastern Mediterranean countries;Boutayeb A;Int J Equity Health,2013
2. Global Health Estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016 [Internet],2018
3. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde;SAÚDE BRASIL 2018: uma análise da situação de saúde e das doenças e agravos crônicos: desafios e perspectivas,2019
4. KDIGO – Kidney Disease: Improving Global Outcomes. Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease;Kidney Int Suppl,2013
5. Chronic Kidney Disease;Webster AC;Lancet,2017